Mdt stock price recently broke above a key trendline

MDT stock price recently broke above a key trendline, suggesting renewed buying interest. The broader medical technology market is projected to grow at 5% CAGR through 2026, favoring Medtronic’s expansion strategy. It benefits from pricing power thanks to its patented and superior products. Fiscal first-quarter EPS estimates have declined 6.8% to $1.23 over the past 90 days. MDT stock price has seen a 3% gain over the past month, supported by strong demand trends in the medical technology sector. Trading volume remains above its 50-day average, hinting at bullish sentiment ahead of fiscal Q3 results.